Publication:
Antiglutamatergic therapy in Alzheimer's disease - effects of lamotrigine - Short communication

Thumbnail Image

Date

1998

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

SPRINGER-VERLAG WIEN

Research Projects

Organizational Units

Journal Issue

Abstract

It has been proposed that excitotoxic damage by glutamatergic hyperactivity is responsible for neurodegeneration in Alzheimer's disease. Lamotrigine (LTG) inhibits presynaptic glutamate release and is considered to be effective in treatment of other neurodegenerative disorders by its cerebroprotective properties. We used LTG in 11 patients with the diagnosis of probable Alzheimer's disease. 300 mg/day administration of LTG improved word recognition, naming and depressed mood on Alzheimer Disease Assessment Scale (ADAS).

Description

Keywords

lamotrigine, glutamate, glutamate release, excitatory neurotransmitter, Alzheimer's disease, neuroprotection, therapy, GLUTAMATE, DEMENTIA, CORTEX, SCALE

Citation

URI

https://hdl.handle.net/11424/223956

Collections

Araştırma Çıktıları

Endorsement

Review

Supplemented By

Referenced By